Oral Thrush

Oral Thrush Comprehensive Study by Type (Pseudomembranous, Erythematous, Hyperplastic, Others), Application (Hospitals, Clinics), Diagnosis Methods (Examination, Biopsy, Endoscopy, Others.), Treatment drugs (Anti-infective Drugs, Anti-fungal Drugs, Mouth and Throat OTC products) Players and Region - Global Market Outlook to 2026

Oral Thrush Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Oral Thrush Market Overview:
Oral thrush is also known as oral candidiasis which is an infection of the mouth caused by Candida species. This infection occurs naturally inside the mouth forming a white layer of infection on the tongue and another part of the oral mucosa. Other Candida species includes as C. tropicalis, C. glabrata, and C. albicans, which account for over 80% of cases collectively. Increasing prevalence of infection such as HIV (immunocompromised) patient who are more prone to oral thrush infection and increasing population of infants and toddlers are contributing to foster the market growth.

Growth Drivers
  • Increasing Prevalence of HIV Infection Patients are More Susceptible to Oral Candidiasis or Oral Thrush Infection
  • Rising Incidences of Candidiasis Infection

Roadblocks
  • Lack of Awareness and Misdiagnosis of the Disease

Opportunities
  • Rising Prevalence of Diabetic Population
  • Increasing Investment in Healthcare Infrastructure to Prevent Disease like Oral Thrush

Challenges
  • Availability of Alternative Treatments such as Digestive Health Probiotics


Competitive Landscape:
The Global Oral thrush market is fragmented with several market players who are involved in a new product launch are being under approval for FDA or approved. For instance, New antifungals such as the echinocandins (eg, caspofungin, micafungin) with pediatric dosing approved by the US Food and Drug Administration (FDA). Another echinocandin, anidulafungin (Eraxis), is also approved but does not have FDA-approved dosing for children.
Some of the key players profiled in the report are Bayer AG (United States), Teva Pharmaceuticals (Israel), Stellar Pharma, Inc. (Canada), Pfizer Inc. (United States), Wockhardt Ltd. (India), Ranbaxy Laboratories Limited (India), Bristol Laboratories (United Kingdom), Glenmark Pharmaceuticals (India) and GlaxoSmithKline Plc (United Kingdom). Considering Market by Diagnosis Methods, the sub-segment i.e. Examination will boost the Oral Thrush market. Considering Market by Treatment drugs, the sub-segment i.e. Anti-infective Drugs will boost the Oral Thrush market.

August 2013, the United States, FDA announced that medical professionals should not prescribe ketoconazole tablet as a first-line therapy for any fungal infection because of the risk of severe liver injury, adverse drug reactions, and adrenal insufficiency.

What Can be Explored with the Oral Thrush Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Oral Thrush Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Oral Thrush
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Oral Thrush market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Oral Thrush market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Oral Thrush Treatment Manufacturers & Suppliers, Research and Development (R&D) Companies, Hospitals and Clinics, Academic Institutes and Universities, Government and Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Pseudomembranous
  • Erythematous
  • Hyperplastic
  • Others
By Application
  • Hospitals
  • Clinics
By Diagnosis Methods
  • Examination
  • Biopsy
  • Endoscopy
  • Others.

By Treatment drugs
  • Anti-infective Drugs
  • Anti-fungal Drugs
  • Mouth and Throat OTC products

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of HIV Infection Patients are More Susceptible to Oral Candidiasis or Oral Thrush Infection
      • 3.2.2. Rising Incidences of Candidiasis Infection
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternative Treatments such as Digestive Health Probiotics
    • 3.4. Market Trends
      • 3.4.1. Increasing Infection of Oral Thrush Among Infants and Toddlers
      • 3.4.2. High Risk of Developing Oral Thrush Among Xerostomia (Dry Mouth) Denture Wearing People
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oral Thrush, by Type, Application, Diagnosis Methods, Treatment drugs and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Oral Thrush (Value)
      • 5.2.1. Global Oral Thrush by: Type (Value)
        • 5.2.1.1. Pseudomembranous
        • 5.2.1.2. Erythematous
        • 5.2.1.3. Hyperplastic
        • 5.2.1.4. Others
      • 5.2.2. Global Oral Thrush by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
      • 5.2.3. Global Oral Thrush by: Diagnosis Methods (Value)
        • 5.2.3.1. Examination
        • 5.2.3.2. Biopsy
        • 5.2.3.3. Endoscopy
        • 5.2.3.4. Others.
      • 5.2.4. Global Oral Thrush by: Treatment drugs (Value)
        • 5.2.4.1. Anti-infective Drugs
        • 5.2.4.2. Anti-fungal Drugs
        • 5.2.4.3. Mouth and Throat OTC products
      • 5.2.5. Global Oral Thrush Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Oral Thrush (Price)
      • 5.3.1. Global Oral Thrush by: Type (Price)
  • 6. Oral Thrush: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva Pharmaceuticals (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Stellar Pharma, Inc. (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Wockhardt Ltd. (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Ranbaxy Laboratories Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bristol Laboratories (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Glenmark Pharmaceuticals (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. GlaxoSmithKline Plc (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Oral Thrush Sale, by Type, Application, Diagnosis Methods, Treatment drugs and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Oral Thrush (Value)
      • 7.2.1. Global Oral Thrush by: Type (Value)
        • 7.2.1.1. Pseudomembranous
        • 7.2.1.2. Erythematous
        • 7.2.1.3. Hyperplastic
        • 7.2.1.4. Others
      • 7.2.2. Global Oral Thrush by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
      • 7.2.3. Global Oral Thrush by: Diagnosis Methods (Value)
        • 7.2.3.1. Examination
        • 7.2.3.2. Biopsy
        • 7.2.3.3. Endoscopy
        • 7.2.3.4. Others.
      • 7.2.4. Global Oral Thrush by: Treatment drugs (Value)
        • 7.2.4.1. Anti-infective Drugs
        • 7.2.4.2. Anti-fungal Drugs
        • 7.2.4.3. Mouth and Throat OTC products
      • 7.2.5. Global Oral Thrush Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Oral Thrush (Price)
      • 7.3.1. Global Oral Thrush by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oral Thrush: by Type(USD Million)
  • Table 2. Oral Thrush Pseudomembranous , by Region USD Million (2015-2020)
  • Table 3. Oral Thrush Erythematous , by Region USD Million (2015-2020)
  • Table 4. Oral Thrush Hyperplastic , by Region USD Million (2015-2020)
  • Table 5. Oral Thrush Others , by Region USD Million (2015-2020)
  • Table 6. Oral Thrush: by Application(USD Million)
  • Table 7. Oral Thrush Hospitals , by Region USD Million (2015-2020)
  • Table 8. Oral Thrush Clinics , by Region USD Million (2015-2020)
  • Table 9. Oral Thrush: by Diagnosis Methods(USD Million)
  • Table 10. Oral Thrush Examination , by Region USD Million (2015-2020)
  • Table 11. Oral Thrush Biopsy , by Region USD Million (2015-2020)
  • Table 12. Oral Thrush Endoscopy , by Region USD Million (2015-2020)
  • Table 13. Oral Thrush Others. , by Region USD Million (2015-2020)
  • Table 14. Oral Thrush: by Treatment drugs(USD Million)
  • Table 15. Oral Thrush Anti-infective Drugs , by Region USD Million (2015-2020)
  • Table 16. Oral Thrush Anti-fungal Drugs , by Region USD Million (2015-2020)
  • Table 17. Oral Thrush Mouth and Throat OTC products , by Region USD Million (2015-2020)
  • Table 18. South America Oral Thrush, by Country USD Million (2015-2020)
  • Table 19. South America Oral Thrush, by Type USD Million (2015-2020)
  • Table 20. South America Oral Thrush, by Application USD Million (2015-2020)
  • Table 21. South America Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 22. South America Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 23. Brazil Oral Thrush, by Type USD Million (2015-2020)
  • Table 24. Brazil Oral Thrush, by Application USD Million (2015-2020)
  • Table 25. Brazil Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 26. Brazil Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 27. Argentina Oral Thrush, by Type USD Million (2015-2020)
  • Table 28. Argentina Oral Thrush, by Application USD Million (2015-2020)
  • Table 29. Argentina Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 30. Argentina Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 31. Rest of South America Oral Thrush, by Type USD Million (2015-2020)
  • Table 32. Rest of South America Oral Thrush, by Application USD Million (2015-2020)
  • Table 33. Rest of South America Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 34. Rest of South America Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 35. Asia Pacific Oral Thrush, by Country USD Million (2015-2020)
  • Table 36. Asia Pacific Oral Thrush, by Type USD Million (2015-2020)
  • Table 37. Asia Pacific Oral Thrush, by Application USD Million (2015-2020)
  • Table 38. Asia Pacific Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 39. Asia Pacific Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 40. China Oral Thrush, by Type USD Million (2015-2020)
  • Table 41. China Oral Thrush, by Application USD Million (2015-2020)
  • Table 42. China Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 43. China Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 44. Japan Oral Thrush, by Type USD Million (2015-2020)
  • Table 45. Japan Oral Thrush, by Application USD Million (2015-2020)
  • Table 46. Japan Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 47. Japan Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 48. India Oral Thrush, by Type USD Million (2015-2020)
  • Table 49. India Oral Thrush, by Application USD Million (2015-2020)
  • Table 50. India Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 51. India Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 52. South Korea Oral Thrush, by Type USD Million (2015-2020)
  • Table 53. South Korea Oral Thrush, by Application USD Million (2015-2020)
  • Table 54. South Korea Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 55. South Korea Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 56. Taiwan Oral Thrush, by Type USD Million (2015-2020)
  • Table 57. Taiwan Oral Thrush, by Application USD Million (2015-2020)
  • Table 58. Taiwan Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 59. Taiwan Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 60. Australia Oral Thrush, by Type USD Million (2015-2020)
  • Table 61. Australia Oral Thrush, by Application USD Million (2015-2020)
  • Table 62. Australia Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 63. Australia Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Oral Thrush, by Type USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Oral Thrush, by Application USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 68. Europe Oral Thrush, by Country USD Million (2015-2020)
  • Table 69. Europe Oral Thrush, by Type USD Million (2015-2020)
  • Table 70. Europe Oral Thrush, by Application USD Million (2015-2020)
  • Table 71. Europe Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 72. Europe Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 73. Germany Oral Thrush, by Type USD Million (2015-2020)
  • Table 74. Germany Oral Thrush, by Application USD Million (2015-2020)
  • Table 75. Germany Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 76. Germany Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 77. France Oral Thrush, by Type USD Million (2015-2020)
  • Table 78. France Oral Thrush, by Application USD Million (2015-2020)
  • Table 79. France Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 80. France Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 81. Italy Oral Thrush, by Type USD Million (2015-2020)
  • Table 82. Italy Oral Thrush, by Application USD Million (2015-2020)
  • Table 83. Italy Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 84. Italy Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 85. United Kingdom Oral Thrush, by Type USD Million (2015-2020)
  • Table 86. United Kingdom Oral Thrush, by Application USD Million (2015-2020)
  • Table 87. United Kingdom Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 88. United Kingdom Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 89. Netherlands Oral Thrush, by Type USD Million (2015-2020)
  • Table 90. Netherlands Oral Thrush, by Application USD Million (2015-2020)
  • Table 91. Netherlands Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 92. Netherlands Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 93. Rest of Europe Oral Thrush, by Type USD Million (2015-2020)
  • Table 94. Rest of Europe Oral Thrush, by Application USD Million (2015-2020)
  • Table 95. Rest of Europe Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 96. Rest of Europe Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 97. MEA Oral Thrush, by Country USD Million (2015-2020)
  • Table 98. MEA Oral Thrush, by Type USD Million (2015-2020)
  • Table 99. MEA Oral Thrush, by Application USD Million (2015-2020)
  • Table 100. MEA Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 101. MEA Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 102. Middle East Oral Thrush, by Type USD Million (2015-2020)
  • Table 103. Middle East Oral Thrush, by Application USD Million (2015-2020)
  • Table 104. Middle East Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 105. Middle East Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 106. Africa Oral Thrush, by Type USD Million (2015-2020)
  • Table 107. Africa Oral Thrush, by Application USD Million (2015-2020)
  • Table 108. Africa Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 109. Africa Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 110. North America Oral Thrush, by Country USD Million (2015-2020)
  • Table 111. North America Oral Thrush, by Type USD Million (2015-2020)
  • Table 112. North America Oral Thrush, by Application USD Million (2015-2020)
  • Table 113. North America Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 114. North America Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 115. United States Oral Thrush, by Type USD Million (2015-2020)
  • Table 116. United States Oral Thrush, by Application USD Million (2015-2020)
  • Table 117. United States Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 118. United States Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 119. Canada Oral Thrush, by Type USD Million (2015-2020)
  • Table 120. Canada Oral Thrush, by Application USD Million (2015-2020)
  • Table 121. Canada Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 122. Canada Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 123. Mexico Oral Thrush, by Type USD Million (2015-2020)
  • Table 124. Mexico Oral Thrush, by Application USD Million (2015-2020)
  • Table 125. Mexico Oral Thrush, by Diagnosis Methods USD Million (2015-2020)
  • Table 126. Mexico Oral Thrush, by Treatment drugs USD Million (2015-2020)
  • Table 127. Oral Thrush: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Oral Thrush: by Type(USD Million)
  • Table 138. Oral Thrush Pseudomembranous , by Region USD Million (2021-2026)
  • Table 139. Oral Thrush Erythematous , by Region USD Million (2021-2026)
  • Table 140. Oral Thrush Hyperplastic , by Region USD Million (2021-2026)
  • Table 141. Oral Thrush Others , by Region USD Million (2021-2026)
  • Table 142. Oral Thrush: by Application(USD Million)
  • Table 143. Oral Thrush Hospitals , by Region USD Million (2021-2026)
  • Table 144. Oral Thrush Clinics , by Region USD Million (2021-2026)
  • Table 145. Oral Thrush: by Diagnosis Methods(USD Million)
  • Table 146. Oral Thrush Examination , by Region USD Million (2021-2026)
  • Table 147. Oral Thrush Biopsy , by Region USD Million (2021-2026)
  • Table 148. Oral Thrush Endoscopy , by Region USD Million (2021-2026)
  • Table 149. Oral Thrush Others. , by Region USD Million (2021-2026)
  • Table 150. Oral Thrush: by Treatment drugs(USD Million)
  • Table 151. Oral Thrush Anti-infective Drugs , by Region USD Million (2021-2026)
  • Table 152. Oral Thrush Anti-fungal Drugs , by Region USD Million (2021-2026)
  • Table 153. Oral Thrush Mouth and Throat OTC products , by Region USD Million (2021-2026)
  • Table 154. South America Oral Thrush, by Country USD Million (2021-2026)
  • Table 155. South America Oral Thrush, by Type USD Million (2021-2026)
  • Table 156. South America Oral Thrush, by Application USD Million (2021-2026)
  • Table 157. South America Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 158. South America Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 159. Brazil Oral Thrush, by Type USD Million (2021-2026)
  • Table 160. Brazil Oral Thrush, by Application USD Million (2021-2026)
  • Table 161. Brazil Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 162. Brazil Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 163. Argentina Oral Thrush, by Type USD Million (2021-2026)
  • Table 164. Argentina Oral Thrush, by Application USD Million (2021-2026)
  • Table 165. Argentina Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 166. Argentina Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 167. Rest of South America Oral Thrush, by Type USD Million (2021-2026)
  • Table 168. Rest of South America Oral Thrush, by Application USD Million (2021-2026)
  • Table 169. Rest of South America Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 170. Rest of South America Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 171. Asia Pacific Oral Thrush, by Country USD Million (2021-2026)
  • Table 172. Asia Pacific Oral Thrush, by Type USD Million (2021-2026)
  • Table 173. Asia Pacific Oral Thrush, by Application USD Million (2021-2026)
  • Table 174. Asia Pacific Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 175. Asia Pacific Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 176. China Oral Thrush, by Type USD Million (2021-2026)
  • Table 177. China Oral Thrush, by Application USD Million (2021-2026)
  • Table 178. China Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 179. China Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 180. Japan Oral Thrush, by Type USD Million (2021-2026)
  • Table 181. Japan Oral Thrush, by Application USD Million (2021-2026)
  • Table 182. Japan Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 183. Japan Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 184. India Oral Thrush, by Type USD Million (2021-2026)
  • Table 185. India Oral Thrush, by Application USD Million (2021-2026)
  • Table 186. India Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 187. India Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 188. South Korea Oral Thrush, by Type USD Million (2021-2026)
  • Table 189. South Korea Oral Thrush, by Application USD Million (2021-2026)
  • Table 190. South Korea Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 191. South Korea Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 192. Taiwan Oral Thrush, by Type USD Million (2021-2026)
  • Table 193. Taiwan Oral Thrush, by Application USD Million (2021-2026)
  • Table 194. Taiwan Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 195. Taiwan Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 196. Australia Oral Thrush, by Type USD Million (2021-2026)
  • Table 197. Australia Oral Thrush, by Application USD Million (2021-2026)
  • Table 198. Australia Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 199. Australia Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Oral Thrush, by Type USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Oral Thrush, by Application USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 204. Europe Oral Thrush, by Country USD Million (2021-2026)
  • Table 205. Europe Oral Thrush, by Type USD Million (2021-2026)
  • Table 206. Europe Oral Thrush, by Application USD Million (2021-2026)
  • Table 207. Europe Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 208. Europe Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 209. Germany Oral Thrush, by Type USD Million (2021-2026)
  • Table 210. Germany Oral Thrush, by Application USD Million (2021-2026)
  • Table 211. Germany Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 212. Germany Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 213. France Oral Thrush, by Type USD Million (2021-2026)
  • Table 214. France Oral Thrush, by Application USD Million (2021-2026)
  • Table 215. France Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 216. France Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 217. Italy Oral Thrush, by Type USD Million (2021-2026)
  • Table 218. Italy Oral Thrush, by Application USD Million (2021-2026)
  • Table 219. Italy Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 220. Italy Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 221. United Kingdom Oral Thrush, by Type USD Million (2021-2026)
  • Table 222. United Kingdom Oral Thrush, by Application USD Million (2021-2026)
  • Table 223. United Kingdom Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 224. United Kingdom Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 225. Netherlands Oral Thrush, by Type USD Million (2021-2026)
  • Table 226. Netherlands Oral Thrush, by Application USD Million (2021-2026)
  • Table 227. Netherlands Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 228. Netherlands Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 229. Rest of Europe Oral Thrush, by Type USD Million (2021-2026)
  • Table 230. Rest of Europe Oral Thrush, by Application USD Million (2021-2026)
  • Table 231. Rest of Europe Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 232. Rest of Europe Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 233. MEA Oral Thrush, by Country USD Million (2021-2026)
  • Table 234. MEA Oral Thrush, by Type USD Million (2021-2026)
  • Table 235. MEA Oral Thrush, by Application USD Million (2021-2026)
  • Table 236. MEA Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 237. MEA Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 238. Middle East Oral Thrush, by Type USD Million (2021-2026)
  • Table 239. Middle East Oral Thrush, by Application USD Million (2021-2026)
  • Table 240. Middle East Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 241. Middle East Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 242. Africa Oral Thrush, by Type USD Million (2021-2026)
  • Table 243. Africa Oral Thrush, by Application USD Million (2021-2026)
  • Table 244. Africa Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 245. Africa Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 246. North America Oral Thrush, by Country USD Million (2021-2026)
  • Table 247. North America Oral Thrush, by Type USD Million (2021-2026)
  • Table 248. North America Oral Thrush, by Application USD Million (2021-2026)
  • Table 249. North America Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 250. North America Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 251. United States Oral Thrush, by Type USD Million (2021-2026)
  • Table 252. United States Oral Thrush, by Application USD Million (2021-2026)
  • Table 253. United States Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 254. United States Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 255. Canada Oral Thrush, by Type USD Million (2021-2026)
  • Table 256. Canada Oral Thrush, by Application USD Million (2021-2026)
  • Table 257. Canada Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 258. Canada Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 259. Mexico Oral Thrush, by Type USD Million (2021-2026)
  • Table 260. Mexico Oral Thrush, by Application USD Million (2021-2026)
  • Table 261. Mexico Oral Thrush, by Diagnosis Methods USD Million (2021-2026)
  • Table 262. Mexico Oral Thrush, by Treatment drugs USD Million (2021-2026)
  • Table 263. Oral Thrush: by Type(USD/Units)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oral Thrush: by Type USD Million (2015-2020)
  • Figure 5. Global Oral Thrush: by Application USD Million (2015-2020)
  • Figure 6. Global Oral Thrush: by Diagnosis Methods USD Million (2015-2020)
  • Figure 7. Global Oral Thrush: by Treatment drugs USD Million (2015-2020)
  • Figure 8. South America Oral Thrush Share (%), by Country
  • Figure 9. Asia Pacific Oral Thrush Share (%), by Country
  • Figure 10. Europe Oral Thrush Share (%), by Country
  • Figure 11. MEA Oral Thrush Share (%), by Country
  • Figure 12. North America Oral Thrush Share (%), by Country
  • Figure 13. Global Oral Thrush: by Type USD/Units (2015-2020)
  • Figure 14. Global Oral Thrush share by Players 2020 (%)
  • Figure 15. Global Oral Thrush share by Players (Top 3) 2020(%)
  • Figure 16. Global Oral Thrush share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Bayer AG (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bayer AG (United States) Revenue: by Geography 2020
  • Figure 20. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 21. Teva Pharmaceuticals (Israel) Revenue: by Geography 2020
  • Figure 22. Stellar Pharma, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Stellar Pharma, Inc. (Canada) Revenue: by Geography 2020
  • Figure 24. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 26. Wockhardt Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 27. Wockhardt Ltd. (India) Revenue: by Geography 2020
  • Figure 28. Ranbaxy Laboratories Limited (India) Revenue, Net Income and Gross profit
  • Figure 29. Ranbaxy Laboratories Limited (India) Revenue: by Geography 2020
  • Figure 30. Bristol Laboratories (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Bristol Laboratories (United Kingdom) Revenue: by Geography 2020
  • Figure 32. Glenmark Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 33. Glenmark Pharmaceuticals (India) Revenue: by Geography 2020
  • Figure 34. GlaxoSmithKline Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. GlaxoSmithKline Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 36. Global Oral Thrush: by Type USD Million (2021-2026)
  • Figure 37. Global Oral Thrush: by Application USD Million (2021-2026)
  • Figure 38. Global Oral Thrush: by Diagnosis Methods USD Million (2021-2026)
  • Figure 39. Global Oral Thrush: by Treatment drugs USD Million (2021-2026)
  • Figure 40. South America Oral Thrush Share (%), by Country
  • Figure 41. Asia Pacific Oral Thrush Share (%), by Country
  • Figure 42. Europe Oral Thrush Share (%), by Country
  • Figure 43. MEA Oral Thrush Share (%), by Country
  • Figure 44. North America Oral Thrush Share (%), by Country
  • Figure 45. Global Oral Thrush: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Bayer AG (United States)
  • Teva Pharmaceuticals (Israel)
  • Stellar Pharma, Inc. (Canada)
  • Pfizer Inc. (United States)
  • Wockhardt Ltd. (India)
  • Ranbaxy Laboratories Limited (India)
  • Bristol Laboratories (United Kingdom)
  • Glenmark Pharmaceuticals (India)
  • GlaxoSmithKline Plc (United Kingdom)
Select User Access Type

Key Highlights of Report


Jan 2022 249 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Oral Thrush Quantitative research analysis
Oral Thrush Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Oral Thrush market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Oral Thrush market are Bayer AG (United States), Teva Pharmaceuticals (Israel), Stellar Pharma, Inc. (Canada), Pfizer Inc. (United States), Wockhardt Ltd. (India), Ranbaxy Laboratories Limited (India), Bristol Laboratories (United Kingdom), Glenmark Pharmaceuticals (India) and GlaxoSmithKline Plc (United Kingdom), to name a few.
"Increasing Infection of Oral Thrush Among Infants and Toddlers " is seen as one of major influencing trends for Oral Thrush Market during projected period 2020-2026.

Know More About Oral Thrush Report?

Have a Query? Click Here

Other Related Reports

Treatment for Communicable Diseases Comprehensive Study by Type (Therapeutics (Antibiotics, Antifungal, Antivirals, Antiparasitics, Others), Vaccines), Application (Hospital, Clinic, Other), Diseases...
$ 3750
Injectable Anti-Wrinkle Comprehensive Study by Type (Muscle Relaxants (Botox Injections, Others), Synthetic Wrinkle Fillers (Sculptra, Radiesse, Silicone), Autologous Wrinkle Fillers, Muscle Relaxant...
$ 3750
Unna Boot Comprehensive Study by Application (Venous Leg Ulcers, Lymphedema, Eczema), Raw Material (Zinc Oxide, Zinc, Calamine), Distribution Channel (Offline Retail, Online Retail) Players and Regi...
$ 3500
RNA Based Therapeutics Comprehensive Study by Application (Cardiovascular, Kidney Diseases, Oncology, Infectious Diseases, Metabolic Disorders, Others), Technology (Inhibition, Microarrays, Labeling,...
$ 3650
Cancer Biological Therapy Comprehensive Study by Type (Monoclonal Antibodies, Vaccines, Cancer Growth Blockers, Blood Cell Growth Factors), Application (Hospitals, Diagnostic Laboratories, Research &...
$ 3650
Ascites Comprehensive Study by Type (Exudate Ascites, Transudative Ascites), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostics Centers, Others), Diagnosis (Angiography, Ultras...
$ 3650